Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Nordea Bank AB (publ) (“Nordea”) in connection with a tender offer and issue of new bonds with an aggregate transaction value of SEK 2,705,000,000
Mandate

Vinge has advised Nordea Bank AB (publ) (“Nordea”) in connection with a tender offer and issue of new bonds with an aggregate transaction value of SEK 2,705,000,000

October 03, 2018 Banking and Finance

Vinge has advised Nordea Bank AB (publ) (“Nordea”) in connection with a tender offer and issue of new bonds with an aggregate transaction value of SEK 2,705,000,000.

Vinge has advised Nordea in connection with Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) tender offer and subsequent repurchase of its previously issued senior and unsecured bonds up to a total amount of SEK 1,205,000,000 (the “Tender Offer”) and its issuance of new senior unsecured bonds with a framework amount of up to SEK 1,500,000,000 (the “New Bonds”).

The initial amount issued under the New Bonds amounts to SEK 1,000,000,000 per 3 October 2018. Nordea was mandated as sole arranger, bookrunner and issuing agent in connection with the New Bonds and as dealer manager, sole bookrunner and tender agent in relation to the Tender Offer.

The New Bonds have a tenor of four years and carry a floating rate interest of STIBOR 3M + 3.60%.

Vinge’s team consisted of Mikael Ståhl, Josefine Larsson and Lionardo Ojeda.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025